Autopsy report · NCT05949294

Study of AROSOD-1 in Adult Participants With Amyotrophic Lateral Sclerosis (ALS)

“Company business decision”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Arrowhead Pharmaceuticals

Sponsor type

Industry

Conditions

Amyotrophic Lateral Sclerosis

Interventions

ARO-SOD1 Injection

Participants

0

Trials that died the same way

• Study to Test the Safety of an Investigational Drug Given Repeatedly to Adult Men With Severe Hemophilia
  “Company decision” (92% match in meaning)
• 3D011-08 Monotherapy in Subjects With Advanced Solid Tumors
  “Company's decision” (89% match in meaning)
• A Study of BTX-1188 in Subjects With Advanced Malignancies
  “Business decision” (88% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.